Humacyte (HUMA) Debt Ratio (2020 - 2025)
Humacyte (HUMA) reported Debt Ratio of 0.23 for Q3 2025, down 58.11% year-over-year from 0.54 in Q3 2024, and down 54.09% quarter-over-quarter from 0.49 in Q2 2025.
Humacyte (HUMA) Debt Ratio (2020 - 2025) Analysis & Trends
Humacyte (HUMA) has 6 years of Debt Ratio data on file, last reported at 0.23 in Q3 2025.
- Debt Ratio for Q3 2025 came in at 0.23, down 58.11% year-over-year; the trailing twelve-month figure through Sep 2025 was 0.23 (down 58.11% YoY), and the FY2024 annual result was 0.47, up 56.81% from the prior year.
- Debt Ratio fell to 0.23 in Q3 2025 per HUMA's latest filing, from 0.49 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.54 in Q3 2024 and troughed at 0.0 in Q1 2021.
- A 5-year average of 0.24 and a median of 0.22 in 2023 frame the typical range for Debt Ratio.
- The sharpest annual moves came in 2021 and 2025: Debt Ratio surged 138056.68% in 2021, then sank 58.11% in 2025.
- A 5-year view of Debt Ratio shows it stood at 0.1 in 2021, then plunged by 56.07% to 0.04 in 2022, then soared by 617.57% to 0.3 in 2023, then surged by 56.81% to 0.47 in 2024, then plunged by 51.98% to 0.23 in 2025.
- Business Quant data shows HUMA's Debt Ratio at 0.23 in Q3 2025, 0.49 in Q2 2025, and 0.41 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 0.18 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Humacyte | 267.09 Mn | 218.55 Mn | -1.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.23 |
| Jun 30, 2025 | 0.49 |
| Mar 31, 2025 | 0.41 |
| Dec 31, 2024 | 0.47 |
| Sep 30, 2024 | 0.54 |
| Jun 30, 2024 | 0.43 |
| Mar 31, 2024 | 0.36 |
| Dec 31, 2023 | 0.30 |
| Jun 30, 2023 | 0.22 |
| Mar 31, 2023 | 0.16 |
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | 0.13 |
| Jun 30, 2022 | 0.11 |
| Mar 31, 2022 | 0.10 |
| Dec 31, 2021 | 0.10 |
| Sep 30, 2021 | 0.06 |
| Mar 31, 2021 | 0.00 |
| Dec 31, 2020 | 0.03 |
| Sep 30, 2020 | 0.00 |